A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.
PHASE2CompletedINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
February 28, 2013
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Conditions
High Grade Cervical Epithelial Neoplasia (CIN2+)
Interventions
DRUG
Cidofovir
Trial Locations (1)
1020
CHU Brugmann Hospital, Brussels
All Listed Sponsors
lead
Brugmann University Hospital
OTHER
NCT02976987 - A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions. | Biotech Hunter | Biotech Hunter